H.R. 6305 · 117th Congress
Protect America’s Biomedical Research Enterprise Act of 2021
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 117th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
R
HudsonSponsor1 cosponsor · 1 D
1 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
This bill requires the Department of Health and Human Services (HHS) to evaluate ways to better protect intellectual property, sensitive medical information, and similar information used in biomedical research and development from national security risks and related threats.
What it does: CRS summary · Introduced in House · Dec 16, 2021
Protect America's Biomedical Research Enterprise Act of 2021
This bill requires the Department of Health and Human Services (HHS) to evaluate ways to better protect intellectual property, sensitive medical information, and similar information used in biomedical research and development from national security risks and related threats.
In particular, HHS must identify national security risks and potential misuse of proprietary information and develop strategies to prevent or mitigate such risks and misuse in federally funded biomedical research and development. HHS must also develop a framework to identify areas of federally funded biomedical research and development that are emerging areas of interest to state actors and regularly review its recommendations and policies related to the protection of biomedical research and development.
In carrying out these activities, HHS must collaborate with relevant federal agencies (such as the Federal Bureau of Investigation) and consult with research institutions, research advocacy organizations, and other experts.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Protect America’s Biomedical Research Enterprise Act of 2021
Latest action (Dec 17, 2021): Referred to the Subcommittee on Health.
Policy area: Health · Origin: House · Introduced: Dec 16, 2021
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.